147 related articles for article (PubMed ID: 12868125)
1. Growth hormone replacement therapy (GHRT) in children and adolescents: skeletal impact.
Mukherjee A; Shalet SM
Med Pediatr Oncol; 2003 Sep; 41(3):235-42. PubMed ID: 12868125
[TBL] [Abstract][Full Text] [Related]
2. Skeletal requirements for optimal growth hormone replacement in the transitional years.
Mukherjee A; Attanasio AF; Shalet SM
Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S130-5. PubMed ID: 12914741
[TBL] [Abstract][Full Text] [Related]
3. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
4. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
5. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
6. Influence of growth hormone on accretion of bone mass.
Monson JP; Drake WM; Carroll PV; Weaver JU; Rodriguez-Arnao J; Savage MO
Horm Res; 2002; 58 Suppl 1():52-6. PubMed ID: 12373015
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
Boot AM; van der Sluis IM; Krenning EP; de Muinck Keizer-Schrama SM
Horm Res; 2009; 71(6):364-71. PubMed ID: 19506395
[TBL] [Abstract][Full Text] [Related]
9. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
[TBL] [Abstract][Full Text] [Related]
10. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
Johannsson G; Sunnerhagen KS; Svensson J
Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone and bone.
Tritos NA; Biller BM
Curr Opin Endocrinol Diabetes Obes; 2009 Dec; 16(6):415-22. PubMed ID: 19770650
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database.
Kreitschmann-Andermahr I; Poll EM; Reineke A; Gilsbach JM; Brabant G; Buchfelder M; Fassbender W; Faust M; Kann PH; Wallaschofski H
Growth Horm IGF Res; 2008 Dec; 18(6):472-8. PubMed ID: 18829359
[TBL] [Abstract][Full Text] [Related]
13. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism.
Kosowicz J; El Ali Z; Ziemnicka K; Sowinski J
J Clin Densitom; 2007; 10(3):332-9. PubMed ID: 17470407
[TBL] [Abstract][Full Text] [Related]
14. Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency?
Aimaretti G; Corneli G; Rovere S; Croce CG; Ghigo E; Procopio M
J Endocrinol Invest; 2005; 28(10 Suppl):28-32. PubMed ID: 16550719
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo controlled study.
Tanriverdi F; Borlu M; Atmaca H; Koc CA; Unluhizarci K; Utas S; Kelestimur F
Clin Endocrinol (Oxf); 2006 Nov; 65(5):579-85. PubMed ID: 17054457
[TBL] [Abstract][Full Text] [Related]
16. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
17. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
Wilhelm B; Kann PH
Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
[TBL] [Abstract][Full Text] [Related]
18. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
Oertel H; Schneider HJ; Stalla GK; Holsboer F; Zihl J
Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
[TBL] [Abstract][Full Text] [Related]
19. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
[TBL] [Abstract][Full Text] [Related]
20. [Growth hormone therapy is useful even for adults].
Viikari J; Välimäki M; Salmi J; Salmela P; Kataja M; Turunen H; Soppi E
Duodecim; 1998; 114(9):867-77. PubMed ID: 11524806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
